Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value
$234.7K
Total Bought
$38.1K
Total Sold
$43.6K
Net Transaction
-$5.5K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BIOMARIN PHARMACEUTICAL INC(BMRN)0405,450+405,4500229.36%+22
UNITED THERAPEUTICS CORP(UTHR)101,14697,646-3,500294117.44%+12
ENANTA PHARMACEUTICALS INC(ENTA)2,114,4442,114,4440162510.78%+9
SANOFI-ADR(SNY)148,946323,946+175,0007156.51%+8
AVADEL PHARMACEUTICALS958,877955,860-3,0178156.22%+6
JAZZ PHARMACEUTICALS PLC(JAZZ)164,816167,816+3,00017229.42%+5
SUPERNUS PHARMACEUTICALS INC(SUPN)472,376363,479-108,89715177.40%+2
BIOGEN INC(BIIB)010,000+10,000010.60%+1
GSK PLC-SPON ADR(GSK)271,729271,729010125.00%+1
VANDA PHARMACEUTICALS INC(VNDA)1,024,8831,180,388+155,505562.51%+1
EVOLUS INC(EOLS)0100,000+100,000010.26%+1
ALKERMES PLC(ALKS)207,822207,8220662.66%0
REGENERON PHARMACEUTICALS(REGN)4,0004,0000220.96%0
BIONTECH SE-ADR(BNTX)73,38279,366+5,984883.33%0
EXELIXIS INC(EXEL)493,526518,526+25,00022219.12%-0
JOHNSON & JOHNSON(JNJ)40,0000-40,00060—-6
INDIVIOR PLC974,474339,532-634,9421483.49%-6
CARDINAL HEALTH INC(CAH)133,74573,745-60,00022124.93%-11
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q3 2025 | TickerTrail